Breaking News Instant updates and real-time market news.

AKAO

Achaogen

$8.34

0.04 (0.48%)

09:02
07/13/18
07/13
09:02
07/13/18
09:02

Achaogen 30% pullback since last month overdone, says William Blair

After attending the company's investor event, William Blair analyst Y. Katherine Xu says shares of Achaogen at current levels offer an attractive entry opportunity. While most of the Street has modeled the use of Zemdri in carbapenem-resistant enterobacteriaceae, extended-spectrum beta-lactamases-producing bacteria is also a major target and represents a much larger population, Xu tells investors in a research note. Further, she believes physicians are and will be comfortable to use Zemdri off-label in blood stream infections and pneumonia. The analyst views the 30% pullback in Achaogen shares since the complicated urinary tract infections approval last month as overdone and thinks her $23 fair value estimate could prove conservative. Xu keeps an Outperform rating on Achaogen.

AKAO Achaogen
$8.34

0.04 (0.48%)

05/03/18
HCWC
05/03/18
NO CHANGE
Target $19
HCWC
Buy
Achaogen price target lowered to $19 from $29 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce lowered his price target for Achaogen to $19 after an FDA panel voted 11-4 against approval of plazomicin for the treatment of bloodstream infections. The analyst believes management may have to redo the calculus of optimizing the drug's market potential with perhaps a lower price than previously expected, but he still likes the shares at the $10-$11 range. He keeps a Buy rating on Achaogen.
05/04/18
RHCO
05/04/18
NO CHANGE
Target $16
RHCO
Buy
Achaogen price target lowered to $16 from $27 at SunTrust
SunTrust analyst Edward Nash lowered his price target on Achaogen to $16, citing yesterday's FDA Advisory Committee vote in favor of plazomicin in the treatment of complicated urinary tract infections but against the treatment of BSI. Nash says the negative outcome for this indication may not prevent its off-label use in BSI, keeping his Buy rating on Achaogen.
05/07/18
GUGG
05/07/18
DOWNGRADE
GUGG
Neutral
Achaogen downgraded to Neutral from Buy at Guggenheim
06/27/18
HCWC
06/27/18
NO CHANGE
Target $19
HCWC
Buy
Achaogen selloff following FDA approval excessive, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce attributes the pullback in Achaogen shares after the company announced yesterday the FDA approval of Zemdri for cUTI to disappointment that the FDA did not also approve plazomicin for CRE infections via a bloodstream infections indication. However, while he believes a BSI indication would have been helpful, he thinks it is "by no means necessary" to successfully market Zemdri for CRE and he calls yesterday's selloff "excessive." Arce affirms a Buy rating on Achaogen shares with a $19 price target.

TODAY'S FREE FLY STORIES

02:40
07/20/18
07/20
02:40
07/20/18
02:40
General news
FX Update: The Dollar has been trading with a softer bias »

FX Update: The Dollar has…

02:35
07/20/18
07/20
02:35
07/20/18
02:35
General news
China bourses in late rally after yuan devaluation »

China bourses in late…

01:50
07/20/18
07/20
01:50
07/20/18
01:50
General news
The PBoC devalued the Yuan »

The PBoC devalued the…

01:45
07/20/18
07/20
01:45
07/20/18
01:45
General news
Asian Market Outlook: »

Asian Market Outlook:…

23:55
07/19/18
07/19
23:55
07/19/18
23:55
General news
Japan's core CPI improved to a 0.8% pace in June »

Japan's core CPI…

YUMC

Yum China

$36.00

-0.8 (-2.17%)

20:46
07/19/18
07/19
20:46
07/19/18
20:46
Downgrade
Yum China rating change at BofA/Merrill »

Yum China downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 10

    Sep

MRSN

Mersana Therapeutics

$11.24

-5.275 (-31.95%)

20:45
07/19/18
07/19
20:45
07/19/18
20:45
Downgrade
Mersana Therapeutics rating change at Leerink »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$13.73

-0.02 (-0.15%)

, HON

Honeywell

$147.57

-1.58 (-1.06%)

20:25
07/19/18
07/19
20:25
07/19/18
20:25
Earnings
Notable companies reporting before tomorrow's openGentex »

Notable companies…

GE

General Electric

$13.73

-0.02 (-0.15%)

HON

Honeywell

$147.57

-1.58 (-1.06%)

SLB

Schlumberger

$66.91

-0.16 (-0.24%)

BHGE

Baker Hughes

$31.75

-0.79 (-2.43%)

STT

State Street

$92.84

-2.505 (-2.63%)

VFC

VF Corp.

$89.21

1 (1.13%)

STI

SunTrust

$69.00

-0.85 (-1.22%)

SWK

Stanley Black & Decker

$139.60

1.33 (0.96%)

RF

Regions Financial

$17.62

-0.43 (-2.38%)

CFG

Citizens Financial

$40.66

-0.365 (-0.89%)

KSU

Kansas City Southern

$108.48

1.93 (1.81%)

GNTX

Gentex

$23.41

-0.41 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 08

    Aug

  • 19

    Oct

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

20:11
07/19/18
07/19
20:11
07/19/18
20:11
Recommendations
Intuitive Surgical analyst commentary  »

Intuitive Surgical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 21

    Aug

  • 27

    Aug

CDNS

Cadence Design

$45.24

-0.29 (-0.64%)

20:04
07/19/18
07/19
20:04
07/19/18
20:04
Hot Stocks
Cadence Design announces Sigrity 2018 release »

Cadence Design announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

AVA

Avista

$50.40

0.06 (0.12%)

19:33
07/19/18
07/19
19:33
07/19/18
19:33
Hot Stocks
Idaho Public Utilities Commission postpones Avista and Hydro One merger hearing »

Hydro One Limited and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

CRK

Comstock Resources

$11.35

-0.2 (-1.73%)

19:28
07/19/18
07/19
19:28
07/19/18
19:28
Hot Stocks
Comstock Resources acquires Haynesville shale assets for $31M »

Comstock Resources, …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

GRPN

Groupon

$4.76

0.04 (0.85%)

, IBM

IBM

$149.25

4.81 (3.33%)

19:16
07/19/18
07/19
19:16
07/19/18
19:16
Periodicals
Groupon lawyer says IBM shakes down other tech companies, Reuters says »

A lawyer for Groupon…

GRPN

Groupon

$4.76

0.04 (0.85%)

IBM

IBM

$149.25

4.81 (3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

WDC

Western Digital

$77.45

-1.33 (-1.69%)

19:06
07/19/18
07/19
19:06
07/19/18
19:06
Hot Stocks
Western Digital begins sampling 1.33 terrabit 3D NAND »

Western Digital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CE

Celanese

$109.84

-1.17 (-1.05%)

, LLNW

Limelight Networks

$4.69

-0.04 (-0.85%)

19:04
07/19/18
07/19
19:04
07/19/18
19:04
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

CE

Celanese

$109.84

-1.17 (-1.05%)

LLNW

Limelight Networks

$4.69

-0.04 (-0.85%)

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

MSFT

Microsoft

$104.70

-0.38 (-0.36%)

SWKS

Skyworks

$102.46

0.41 (0.40%)

COF

Capital One

$95.32

-1.77 (-1.82%)

ETFC

E-Trade

$61.20

-1.94 (-3.07%)

PTCT

PTC Therapeutics

$36.61

1.59 (4.54%)

RWT

Redwood Trust

$16.64

0.135 (0.82%)

AEP

American Electric

$70.65

0.41 (0.58%)

WEC

WEC Energy

$65.23

0.51 (0.79%)

SKX

Skechers

$33.24

0.61 (1.87%)

FTD

FTD Companies

$4.52

0.06 (1.35%)

ZYNE

Zynerba

$10.40

0.24 (2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 20

    Jul

  • 25

    Jul

  • 02

    Aug

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 21

    Aug

  • 27

    Aug

  • 04

    Sep

  • 20

    Jul

BG

Bunge

$67.99

-0.43 (-0.63%)

19:04
07/19/18
07/19
19:04
07/19/18
19:04
Periodicals
Bunge in talks to sell part of sugar trading unit to Wilmar, Bloomberg says »

Bunge is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

PEG

PSEG

$52.18

0.42 (0.81%)

18:42
07/19/18
07/19
18:42
07/19/18
18:42
Downgrade
PSEG rating change at Goldman Sachs »

PSEG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEC

WEC Energy

$65.23

0.51 (0.79%)

18:41
07/19/18
07/19
18:41
07/19/18
18:41
Upgrade
WEC Energy rating change at Goldman Sachs »

WEC Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEP

American Electric

$70.65

0.41 (0.58%)

18:41
07/19/18
07/19
18:41
07/19/18
18:41
Upgrade
American Electric rating change at Goldman Sachs »

American Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ETR

Entergy

$80.97

0.465 (0.58%)

18:40
07/19/18
07/19
18:40
07/19/18
18:40
Upgrade
Entergy rating change at Goldman Sachs »

Entergy upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$89.45

-0.6 (-0.67%)

, INCY

Incyte

$70.10

-0.3 (-0.43%)

18:33
07/19/18
07/19
18:33
07/19/18
18:33
Hot Stocks
Lancet study shows benefit of Baricitinib 4 mg for treatment of SLE »

Eli Lilly (LLY) and…

LLY

Eli Lilly

$89.45

-0.6 (-0.67%)

INCY

Incyte

$70.10

-0.3 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 31

    Jul

  • 10

    Sep

T

AT&T

$31.27

-0.46 (-1.45%)

18:20
07/19/18
07/19
18:20
07/19/18
18:20
Periodicals
U.S. court clears expedited appeal of AT&T-Time Warner deal, Reuters says »

A federal appeals court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 09

    Aug

VLKAY

Volkswagen

$0.00

(0.00%)

18:17
07/19/18
07/19
18:17
07/19/18
18:17
Periodicals
VW to furlough roughly 1,000 workers at biggest factory in Brazil, Reuters says »

Volkswagen intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,187.14

-8.67 (-0.73%)

, GOOGL

Alphabet Class A

$1,199.26

-13.38 (-1.10%)

18:09
07/19/18
07/19
18:09
07/19/18
18:09
Periodicals
Google faces uphill but not insurmountable fight to appeal EU fine, WSJ says »

Google (GOOG) parent…

GOOG

Alphabet

$1,187.14

-8.67 (-0.73%)

GOOGL

Alphabet Class A

$1,199.26

-13.38 (-1.10%)

INTC

Intel

$52.01

0.3 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 08

    Aug

  • 14

    Aug

  • 18

    Sep

  • 28

    Oct

NWE

NorthWestern

$58.29

0.56 (0.97%)

18:03
07/19/18
07/19
18:03
07/19/18
18:03
Earnings
Breaking Earnings news story on NorthWestern »

NorthWestern reaffirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.